Senior Vice President, Supply Chain, as of 1 January 2019 and Chairman of the Board of Fermion Oy as of 1 January 2014
Career in Orion:
2019- Senior Vice President, Supply Chain
2014- Chairman of the Board of Fermion Oy
2014-2018 Senior Vice President, Specialty Products
2008-2013 Senior Vice President, Proprietary Products
2005-2007 Head of Urology and Oncology business
2004-2005 Program Leader of pharmaceutical development projects for Hormonal and Urological therapies
2002-2004 Portfolio Manager
2001-2002 Project Manager
1999-2001 Researcher and Project Manager, Hormonal therapies
Earlier career:
1995-1999 Senior Research Associate, Pharmacia & Upjohn, Diagnostics (Sweden) and ELIAS GmbH (Germany) and Institute Pasteur (France)
Former key positions of trust
Member of the Board: PharmaService Oy 2014-2016, Finnish Bioindustries FIB 2010-2016
Member of the Economic & Social Policy Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA) 2010-2015, Member of the Healthcare Sector Committee of the National Emergency Supply Organisation, NESO, 2014-2015
Liisa Hurme completed her doctoral thesis on biochemistry at the University of Helsinki, Faculty of Science, in 1996.
Org chart
Teams
Offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.
